(Sharecast News) - Pfizer raised its full-year profit forecast on Tuesday after reporting second-quarter earnings and revenue that exceeded Wall Street expectations, driven by strong sales of key products and progress in cost-cutting initiatives.
The pharmaceuticals giant posted adjusted earnings per share of 78 cents, well above analysts' estimates of 58...

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE